Potential role of RNAi in the treatment of HCV infection

References

• Hoofnagle JH. Course and outcome of hepatitis C. Hepatology36(5 Suppl. 1), S21–S29 (2002).
   PubMed Web of Science ®Google Scholar
• Fishman JA, Rubin RH, Koziel MJ, Periera BJ. Hepatitis C virus and organ transplantation. Transplantation62(2), 147–154 (1996).
   PubMed Web of Science ®Google Scholar
• Alter MJ. Epidemiology of hepatitis C virus infection. World J. Gastroenterol.13(17), 2436–2441 (2007).
   PubMed Web of Science ®Google Scholar
• Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis.20(1), 17–35 (2000).
   PubMed Web of Science ®Google Scholar
• Bowen DG, Walker CM. The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection? J. Hepatol.42(3), 408–417 (2005).
   PubMed Web of Science ®Google Scholar
• Lohmann V, Koch JO, Bartenschlager R. Processing pathways of the hepatitis C virus proteins. J. Hepatol.24(Suppl. 2), 11–19 (1996).
   PubMed Web of Science ®Google Scholar
• Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. Structural biology of hepatitis C virus. Hepatology39(1), 5–19 (2004).
   PubMed Web of Science ®Google Scholar
• Moradpour D, Brass V, Bieck E et al. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol.78(23), 13278–13284 (2004).
   PubMed Web of Science ®Google Scholar
• Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science285(5424), 110–113 (1999).
   PubMed Web of Science ®Google Scholar
• Krieger N, Lohmann V, Bartenschlager R. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol.75(10), 4614–4624 (2001).
   PubMed Web of Science ®Google Scholar
• Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science290(5498), 1972–1974 (2000).
   PubMed Web of Science ®Google Scholar
• Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol.76(24), 13001–13014 (2002).
   PubMed Web of Science ®Google Scholar
• Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science309(5734), 623–626 (2005).
   PubMed Web of Science ®Google Scholar
• Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med.11(7), 791–796 (2005).
   PubMed Web of Science ®Google Scholar
• Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA102(26), 9294–9299 (2005).
   PubMed Web of Science ®Google Scholar
• Cai Z, Zhang C, Chang KS et al. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J. Virol.79, 13963–13973 (2005).
   PubMed Web of Science ®Google Scholar
• Kanda T, Basu A, Steele R et al. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol.80(9), 4633–4639 (2006).
   PubMed Web of Science ®Google Scholar
• Lazaro CA, Chang M, Tang W et al. Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes. Am. J. Pathol.170(2), 478–489 (2007).
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev.15(2), 188–200 (2001).
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J.20(23), 6877–6888 (2001).
   PubMed Web of Science ®Google Scholar
• Hamilton AJ, Baulcombe DC. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science286, 950–952 (1999).
   PubMed Web of Science ®Google Scholar
• Napoli C, Lemieux C, Jorgensen R. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell2, 279–289 (1990).
   PubMed Web of Science ®Google Scholar
• Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature391(6669), 806–811 (1998).
   PubMed Web of Science ®Google Scholar
• Kennerdell JR, Carthew RW. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway Cell95(7), 1017–1026 (1998).
   PubMed Web of Science ®Google Scholar
• Misquitta L, Paterson BM. Targeted disruption of gene function in Drosophila by RNA interference (RNA-i), a role for nautilus in embryonic somatic muscle formation. Proc. Natl Acad. Sci. USA96(4), 1451–1456 (1999).
   PubMed Web of Science ®Google Scholar
• Ngo H, Tschudi C, Gull K, Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc. Natl Acad. Sci. USA.95(25), 14687–14692 (1998).
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods26(2), 199–213 (2002).
   PubMed Web of Science ®Google Scholar
• Wianny F, Zernicka-Goetz M. Specific interference with gene function by double-stranded RNA in early mouse development. Nat. Cell Biol.2(2), 70–75 (2000).
   PubMed Web of Science ®Google Scholar
• Yang S, Tutton S, Pierce E, Yoon K. Specific double-stranded RNA interference in undifferentisted mouse embryonic stem cells. Mol. Cell. Biol.21(22), 7807–7816 (2001).
   PubMed Web of Science ®Google Scholar
• Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell101(1), 25–33 (2000).
   PubMed Web of Science ®Google Scholar
• Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev. Biol.216(2), 671–680 (1999).
   PubMed Web of Science ®Google Scholar
• Tang G, Reinhart BJ, Bartel DP, Zamore PD. A biochemical framework for RNA silencing in plants. Genes Dev.17(1), 49–63 (2003).
   PubMed Web of Science ®Google Scholar
• Hamilton A, Voinnet O, Chappell L, Baulcombe D. Two classes of short interfering RNA in RNA silencing. EMBO J.21(17), 4671–4679 (2002).
   PubMed Web of Science ®Google Scholar
• Volpe TA, Kidner C, Hall IM, Teng G, Grewal SI, Martienssen RA. Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science297(5588), 1833–1837 (2002).
   PubMed Web of Science ®Google Scholar
• Hall IM, Shankaranarayana GD, Noma K, Ayoub N, Cohen A, Grewal SI. Establishment and maintenance of a heterochromatin domain. Science297(5590), 2232–2237 (2002).
   PubMed Web of Science ®Google Scholar
• Mochizuki K, Fine NA, Fujisawa T, Gorovsky MA. Analysis of a piwi-related gene implicates small RNAs in genome rearrangement in tetrahymena. Cell110(6), 689–699 (2002).
   PubMed Web of Science ®Google Scholar
• Bosher JM, Labouesse M. RNA interference: genetic wand and genetic watchdog. Nat. Cell Biol.2(2), E31–E36 (2000).
   PubMedGoogle Scholar
• Hannon GJ. RNA interference. Nature418(6894), 244–251 (2002).
   PubMed Web of Science ®Google Scholar
• Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature409(6818), 363–366 (2001).
   PubMed Web of Science ®Google Scholar
• Nykanen A, Haley B, Zamore PD. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell107(3), 309–321 (2001).
   PubMed Web of Science ®Google Scholar
• Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature404(6775), 293–296 (2000).
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature411, 494–498 (2001).
   PubMed Web of Science ®Google Scholar
• Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl Acad. Sci. USA.98(17), 9742–9747 (2001).
   PubMed Web of Science ®Google Scholar
• Billy E, Brondani V, Zhang H, Muller U, Filipowicz W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl Acad. Sci. USA98(25), 14428–14433 (2001).
   PubMed Web of Science ®Google Scholar
• Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol.5(9), 834–839 (2003).
   PubMed Web of Science ®Google Scholar
• Persengiev SP, Zhu X, Green MR. Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA10(1), 12–18 (2004).
   PubMed Web of Science ®Google Scholar
• Almeida R, Allshire RC. RNA silencing and genome regulation. Trends Cell Biol.15(5), 251–258 (2005).
   PubMed Web of Science ®Google Scholar
• Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science309(5740), 1519–1524 (2005).
   PubMed Web of Science ®Google Scholar
• Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res.31(11), 2717–2724 (2003).
   PubMed Web of Science ®Google Scholar
• Kronke J, Kittler R, Buchholz F et al. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. J. Virol.78, 3436–3446 (2004).
   PubMed Web of Science ®Google Scholar
• Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc. Natl Acad. Sci. USA100, 2014–2018 (2003).
   PubMed Web of Science ®Google Scholar
• Yokota T, Sakamoto N, Enomoto N et al. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep.4, 602–608 (2003).
   PubMed Web of Science ®Google Scholar
• Wilson JA, Jayasena S, Khvorova A et al. RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl Acad. Sci. USA100, 2783–2788 (2003).
   PubMed Web of Science ®Google Scholar
• Randall G, Grakoui A, Rice CM. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc. Natl Acad. Sci. USA100, 235–240 (2003).
   PubMed Web of Science ®Google Scholar
• Seo MY, Abrignani S, Houghton M, Han JH. Small interfering RNA-mediated inhibition of hepatitis C virus replication in the human hepatoma cell line Huh-7. J. Virol.77(1), 810–812 (2003).
   PubMed Web of Science ®Google Scholar
• Korf M, Meyer A, Jarczak D, Beger C, Manns MP, Kruger M. Inhibition of HCV subgenomic replicons by siRNAs derived from plasmids with opposing U6 and H1 promoters. J. Viral. Hepat.14(2), 122–132 (2007).
   PubMed Web of Science ®Google Scholar
• Smith RM, Smolic R, Volarevic M, Wu GY. Positional effects and strand preference of RNA interference against hepatitis C virus target sequences. J. Viral. Hepat.14(3), 194–212 (2007).
   PubMed Web of Science ®Google Scholar
• Kanda T, Steele R, Ray R, Ray RB. Small interfering RNA targeted to hepatitis C virus 5´ nontranslated region exerts potent antiviral effect. J. Virol.81(2), 669–676 (2007).
   PubMed Web of Science ®Google Scholar
• Prabhu R, Garry RF, Dash S. Small interfering RNA targeted to stem-loop II of the 5´ untranslated region effectively inhibits expression of six HCV genotypes. Virol. J.27(3), 100 (2006).
   Google Scholar
• Prabhu R, Vittal P, Yin Q et al. Small interfering RNA effectively inhibits protein expression and negative strand RNA synthesis from a full-length hepatitis C virus clone. J. Med. Virol.76(4), 511–519 (2005).
   PubMed Web of Science ®Google Scholar
• Domitrovich AM, Diebel KW, Ali N, Sarker S, Siddiqui A. Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication. Virology335(1), 72–86 (2005).
   PubMed Web of Science ®Google Scholar
• Chang KS, Luo G. The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA. Virus Res.115(1), 1–8 (2005).
   PubMed Web of Science ®Google Scholar
• Hamamoto I, Nishimura Y, Okamoto T et al. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J. Virol.79(21), 13473–13482 (2005).
   PubMed Web of Science ®Google Scholar
• Lan S, Wang H, Jiang H et al. Direct interaction between α-actinin and hepatitis C virus NS5B. FEBS Lett.554(3), 289–294 (2003).
   PubMed Web of Science ®Google Scholar
• Mannova P, Beretta L. Activation of the N-Ras–PI3K–Akt–mTOR pathway by hepatitis C virus: control of cell survival and viral replication. J. Virol.79(14), 8742–8749 (2005).
   PubMed Web of Science ®Google Scholar
• Wilson J A, Richardson, CD. Hepatitis C virus replicons escape RNA interference induced by a short interfering RNA directed against the NS5b coding region. J. Virol.79, 7050–7058 (2005).
   PubMed Web of Science ®Google Scholar
• Harris D, Zhang Z, Chaubey B, Pandey VN. Identification of cellular factors associated with the 3´-nontranslated region of the hepatitis C virus genome. Mol. Cell Proteomics5(6), 1006–1018 (2006).
   PubMed Web of Science ®Google Scholar
• Konishi M, Wu CH, Kaito M et al. siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J. Viral. Hepat.13(11), 756–761 (2006).
   PubMed Web of Science ®Google Scholar
• De Francesco R, Migliaccio G. Challenges and successes in developing new therapies for hepatitis C. Nature436(7053), 953–960 (2005).
   PubMed Web of Science ®Google Scholar
• Wang Y, Kato N, Jazag A et al. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology130(3), 883–892 (2006).
   PubMed Web of Science ®Google Scholar
• Korf M, Jarczak D, Beger C, Manns MP, Kruger M. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. J. Hepatol.43(2), 225–234 (2005).
   PubMed Web of Science ®Google Scholar
• Jarczak D, Korf M, Beger C, Manns MP, Kruger M. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons. FEBS J.272(22), 5910–5922 (2005).
   PubMed Web of Science ®Google Scholar
• Jackson AL, Linsley PS. Noise amidst the silence: off-target effects of siRNAs? Trends Genet.20(11), 521–524 (2004).
   PubMed Web of Science ®Google Scholar
• Grimm D, Streetz KL, Jopling CL et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature441(7092), 537–541 (2006).
   Google Scholar
• Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol.23(4), 457–462 (2005).
   PubMed Web of Science ®Google Scholar
• Braasch DA, Paroo Z, Constantinescu A et al. Biodistribution of phosphodiester and phosphorothioate siRNA. Bioorg. Med. Chem. Lett.14, 1139–1143 (2004).
   PubMed Web of Science ®Google Scholar
• Kakizawa Y, Furukawa S, Kataoka K. Block copolymer-coated calcium phosphate nanoparticles sensing intracellular environment for oligodeoxynucleotide and siRNA delivery. J. Control. Release97(2), 345–356 (2004).
   PubMed Web of Science ®Google Scholar
• Simeoni F, Morris MC, Heitz F, Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res.31(11), 2717–2724 (2003).
   PubMed Web of Science ®Google Scholar
• Song E, Lee SK, Wang J et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med.9, 347–351 (2003).
   PubMed Web of Science ®Google Scholar
• McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature418, 38–39 (2002).
   PubMed Web of Science ®Google Scholar
• Lewis DL, Wolff JA. Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Meth. Enzymol.392, 336–350 (2005).
   PubMed Web of Science ®Google Scholar
• Uprichard SL, Boyd B, Althage A, Chisari FV. Clearance of hepatitis B virus from the liver of transgenic mice by short hairpin RNAs. Proc. Natl Acad. Sci. USA102, 773–778 (2005).
   PubMed Web of Science ®Google Scholar
• Morrissey DV, Lockridge JA, Shaw L et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol.23(8), 1002–1007 (2005).
   PubMed Web of Science ®Google Scholar
• Landen CN Jr, Chavez-Reyes A, Bucana C et al. Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res.65(15), 6910–6918 (2005).
   PubMed Web of Science ®Google Scholar
• Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol.327(4), 761–766 (2003).
   PubMed Web of Science ®Google Scholar
• Urban-Klein B, Werth S, Abuharbeid S, Czubayko F, Aigner A. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther.12(5), 461–466 (2005).
   PubMed Web of Science ®Google Scholar
• Song E, Zhu P, Lee SK et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol.23(6), 709–717 (2005).
   PubMed Web of Science ®Google Scholar
• Kim SI, Shin D, Choi TH et al. Systemic and specific delivery of small interfering RNAs to the liver mediated by apolipoprotein A-I. Mol. Ther.15(6), 1145–1152 (2007).
   PubMed Web of Science ®Google Scholar
• Wen WH, Liu JY, Qin WJ et al. Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery. Hepatology46(1), 84–94 (2007).
   PubMed Web of Science ®Google Scholar
• Soutschek J, Akinc A, Bramlage B et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature432, 173–178 (2004).
   PubMed Web of Science ®Google Scholar
• Morrissey DV, Blanchard K, Shaw L et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology41(6), 1349–1356 (2005).
   PubMed Web of Science ®Google Scholar
• Randall G. Progress toward the therapy of hepatitis with RNA interference. Hepatology41, 1220–1222 (2005).
   PubMed Web of Science ®Google Scholar
• Zimmermann TS, Lee AC, Akinc A et al. RNAi-mediated gene silencing in non-human primates. Nature 4,441(7089), 111–114 (2006).
   PubMed Web of Science ®Google Scholar
• Feld JJ, Hoofnagle JH. Mechanism of action of interferon and ribavirin in treatment of hepatitis C. Nature436(7053), 967–972 (2005).
   PubMed Web of Science ®Google Scholar